Search

Your search keyword '"C. Götting"' showing total 107 results

Search Constraints

Start Over You searched for: Author "C. Götting" Remove constraint Author: "C. Götting" Language english Remove constraint Language: english
107 results on '"C. Götting"'

Search Results

1. Sémont Maneuver for Benign Paroxysmal Positional Vertigo Treatment: Moving in the Correct Plane Matters.

2. Xylosyltransferase II is the predominant isoenzyme which is responsible for the steady-state level of xylosyltransferase activity in human serum.

3. Pyrophosphates as a major inhibitor of matrix calcification in Pseudoxanthoma elasticum.

4. ABCC6- a new player in cellular cholesterol and lipoprotein metabolism?

5. Effects of n-3 polyunsaturated fatty acids (PUFAs) on circulating adiponectin and leptin in subjects with type 2 diabetes mellitus.

6. New insights into the pathogenesis of pseudoxanthoma elasticum and related soft tissue calcification disorders by identifying genetic interactions and modifiers.

7. Acute macrovascular dysfunction in patients with type 2 diabetes induced by ingestion of advanced glycated β-lactoglobulins.

8. First identification and functional analysis of the human xylosyltransferase II promoter.

9. Autologous stem cell therapy in the treatment of limb ischaemia induced chronic tissue ulcers of diabetic foot patients.

10. Benfotiamine counteracts smoking-induced vascular dysfunction in healthy smokers.

11. Decorin GAG synthesis and TGF-β signaling mediate Ox-LDL-induced mineralization of human vascular smooth muscle cells.

12. Analysis of MMP2 promoter polymorphisms in patients with pseudoxanthoma elasticum.

13. Centrifugal fundus abnormalities in pseudoxanthoma elasticum.

14. Involvement of a cysteine protease in the secretion process of human xylosyltransferase I.

15. Sample cleanup-free determination of mycophenolic acid and its glucuronide in serum and plasma using the novel technology of ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry.

16. Effects of n-3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus.

17. Simultaneous measurement of amiodarone and desethylamiodarone in human plasma and serum by stable isotope dilution liquid chromatography-tandem mass spectrometry assay.

18. Differences in gene expression of human xylosyltransferases and determination of acceptor specificities for various proteoglycans.

19. Identification and characterization of the human xylosyltransferase I gene promoter region.

20. Increased serum xylosyltransferase activity in patients with liver fibrosis.

21. Fundus autofluorescence in Pseudoxanthoma elasticum.

22. Elevated circulating levels of matrix metalloproteinases MMP-2 and MMP-9 in pseudoxanthoma elasticum patients.

23. Vascular endothelial growth factor gene polymorphisms as prognostic markers for ocular manifestations in pseudoxanthoma elasticum.

24. Quantitative determination and comparison of the glycosaminoglycan Delta-disaccharide composition in 22 different human cell lines.

25. Characterization of the ATP-binding cassette transporter gene expression profile in Y79: a retinoblastoma cell line.

26. A randomized controlled trial on the efficacy of carbohydrate-reduced or fat-reduced diets in patients attending a telemedically guided weight loss program.

27. Circulating calcitriol concentrations and total mortality.

28. Analysis of xylosyltransferase II binding to the anticoagulant heparin.

29. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers.

30. Xylosyltransferase gene variants and their role in essential hypertension.

31. Determination of beta4-galactosyltransferase-7 activity using high-performance liquid chromatography-electrospray ionization tandem mass spectrometry.

32. Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches.

33. First in-gel detection and purification of human xylosyltransferase II.

34. High xylosyltransferase activity in children and during mineralization of osteoblast-like SAOS-2 cells.

35. Calcitriol deficiency and 1-year mortality in cardiac transplant recipients.

36. Measurement of mycophenolic acid and its glucuronide using a novel rapid liquid chromatography-electrospray ionization tandem mass spectrometry assay.

37. The xylosyltransferase Iota gene polymorphism c.343G>T (p.A115S) is associated with decreased serum glycosaminoglycan levels.

38. Gene expression profiling of ABC transporters in dermal fibroblasts of pseudoxanthoma elasticum patients identifies new candidates involved in PXE pathogenesis.

39. Identification of a xylosyltransferase II gene haplotype marker for diabetic nephropathy in type 1 diabetes.

40. Leptin decreases postprandially in people with type 2 diabetes, an effect reduced by the cooking method.

41. Serum xylosyltransferase activity in diabetic patients as a possible marker of reduced proteoglycan biosynthesis.

42. Complement factor H variant p.Y402H in pseudoxanthoma elasticum patients.

43. Elevated serum levels of intercellular adhesion molecule ICAM-1 in Pseudoxanthoma elasticum.

44. Quantitative determination of the glycosaminoglycan Delta-disaccharide composition of serum, platelets and granulocytes by reversed-phase high-performance liquid chromatography.

45. Xylosyltransferase I variants and their impact on abdominal aortic aneurysms.

46. Circulating P-, L- and E-selectins in pseudoxanthoma elasticum patients.

47. The local calcification inhibitor matrix Gla protein in pseudoxanthoma elasticum.

48. Dietary advanced glycation endproducts and oxidative stress: in vivo effects on endothelial function and adipokines.

50. Poor outcome in end-stage heart failure patients with low circulating calcitriol levels.

Catalog

Books, media, physical & digital resources